Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K7 | O43318 | 17/20 | 0.51 |
| ▸ | TAB1 | Q15750 | 17/20 | 0.51 |
| ▸ | ABL1 | P00519 | 2/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16948719 | 1.00 | MAP3K7 (0.51) | MAP3K7TAB1ABL1MTNR1AMTNR1B | |
| SCHEMBL16932976 | 0.89 | MAP3K7 (0.58) | MAP3K7TAB1MTNR1AMTNR1B | |
| SCHEMBL16932974 | 0.89 | MAP3K7 (0.58) | MAP3K7TAB1MTNR1AMTNR1B | |
| SCHEMBL16949265 | 0.80 | MAP3K7 (0.59) | MAP3K7TAB1MTNR1AMTNR1B | |
| SCHEMBL18238757 | 0.80 | MAP3K7 (0.59) | MAP3K7TAB1MTNR1AMTNR1B | |
| SCHEMBL18238764 | 0.79 | MAP3K7 (0.60) | MAP3K7TAB1MTNR1AMTNR1B | |
| SCHEMBL16948727 | 0.79 | MAP3K7 (0.60) | MAP3K7TAB1MTNR1AMTNR1B | |
| SCHEMBL18250495 | 0.78 | MAP3K7 (0.46) | MAP3K7TAB1ABL1MTNR1AMTNR1B | |
| SCHEMBL18238635 | 0.78 | MAP3K7 (0.51) | MAP3K7TAB1 | |
| SCHEMBL16948681 | 0.78 | MAP3K7 (0.51) | MAP3K7TAB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9499551-B2 | Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseases | CONFLUENCE LIFE SCIENCES, INC. (US) | 2016-11-22 | — | — | US | disclosed |